Alerts will be sent to your verified email
Verify EmailMANKIND
|
Mankind Pharma
|
Lupin
|
Zydus Lifesciences
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Pharmaceuticals
|
|||
|
Number of ANDA's Filed in USA
|
67.0 . | 430.0 . | 508.0 . |
|
Number of ANDA's Approved By USFDA
|
48.0 . | 344.0 . | 435.0 . |
|
Domestic Sales Growth - YoY
|
9.8 % | 11.2 % | 12.0 % |
|
R&D as a % of Total Sales
|
2.2 % | 7.5 % | 9.2 % |
|
Unclassified
|
|||
|
Advertisement Spend as a % of Total Sales
|
6.19 % | n/a | n/a |
|
Financials
|
|||
|
5 yr Average ROE
|
20.33 % | 8.95 % | 18.47 % |
|
5yr average Equity Multiplier
|
1.46 | 1.73 | 1.52 |
|
5yr Average Asset Turnover Ratio
|
0.81 | 0.75 | 0.66 |
|
5yr Avg Net Profit Margin
|
17.68 % | 5.06 % | 19.02 % |
|
Price to Book
|
6.41 | 5.04 | 4.2 |
|
P/E
|
54.65 | 21.23 | 22.58 |
|
5yr Avg Cash Conversion Cycle
|
-13.08 Days | -84.38 Days | -84.89 Days |
|
Inventory Days
|
59.06 Days | 53.29 Days | 36.38 Days |
|
Days Receivable
|
34.35 Days | 50.0 Days | 36.93 Days |
|
Days Payable
|
121.69 Days | 160.27 Days | 160.15 Days |
|
5yr Average Interest Coverage Ratio
|
46.07 | 6.26 | 30.19 |
|
5yr Avg ROCE
|
25.06 % | 10.02 % | 19.65 % |
|
5yr Avg Operating Profit Margin
|
24.62 % | 14.15 % | 24.4 % |
|
5 yr average Debt to Equity
|
0.16 | 0.3 | 0.17 |
|
5yr CAGR Net Profit
|
9.49 % | 21.95 % | 16.23 % |
|
5yr Average Return on Assets
|
14.46 % | 3.91 % | 12.22 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
72.66 % | 46.86 % | 75.0 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-3.84 % | -0.22 % | 0.02 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
8.53 % | -0.03 % | -0.71 % |
|
Mankind Pharma
|
Lupin
|
Zydus Lifesciences
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
|
Acute vs Chronic
|
Acute vs Chronic
|
Acute vs Chronic
|
-
|
|
Brand Wise Break-Up
|
Brand Wise Break-Up
|
-
|
-
|